Tamgene Salamat Pars

Tamgene Salamat Pars is a leading biotechnology research company dedicated to advancing healthcare through innovative solutions. As a subsidiary of HITCO Holding, Tamgene Salamat Pars focuses on the production of specialty biotechnological medicines, including Molecular Anti-Bodies (MAB), with a commitment to improving patient outcomes.

Established in 2019, Tamgene Salamat Pars envisions a prosperous future by offering effective treatment solutions within the context of biological advancements at fair and moderate prices. While rooted in Iran, Tamgene Salamat Pars plans to expand its reach by exporting products to neighboring countries, ensuring broader access to its cutting-edge medicines.

Tamgene Salamat Pars is dedicated to innovation and excellence in the biotechnology sector. We invite the management of Tamgene Salamat Pars to create a customized and exclusive company showcase and product listing on our platform, enhancing its visibility and commercial opportunities.